A phase II study of alternating paclitaxel and carboplatin in patients with advanced ovarian cancer

被引：0
|
作者：
Adams, M
Mort, D
Coleman, R
Wiliams, L
Evans, A
Thompson, M
机构：
[1] VELINDRE HOSP NHS TRUST,CARDIFF,S GLAM,WALES
[2] WESTON PK HOSP TRUST,SHEFFIELD,S YORKSHIRE,ENGLAND
[3] BRISTOL MYERS SQUIBB,PHARMACEUT RES INST,HOUNSLOW,ENGLAND
来源：
EUROPEAN JOURNAL OF CANCER | 1995年 / 31A卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：496 / 496
页数：1
相关论文
共 50 条
  • [31] Phase II study of paclitaxel/carboplatin in urothelial cancer
    Zielinski, CC
    Schnack, B
    Grbovic, M
    Brodowicz, T
    Wiltschke, C
    Steger, G
    Pflüger, H
    Marberger, M
    SEMINARS IN ONCOLOGY, 1999, 26 (01) : 138 - 138
  • [32] A Phase II Study of Paclitaxel and Carboplatin with a Biweekly Schedule in Patients with Epithelial Ovarian Cancer: Gynecologic Cancer Network Trial
    Yoneyama, Koichi
    Konishe, Hideki
    Yahata, Tetsuro
    Fujita, Kazuyuki
    Aoki, Yoichi
    Doi, Daisuke
    Matsushima, Takashi
    Kodama, Shoji
    Honma, Shigeru
    Kato, Hisamori
    Nakayama, Hiroki
    Kamoi, Seiryu
    Asakura, Hirobumi
    Takeshita, Toshiyuki
    Tanaka, Kenichi
    JOURNAL OF NIPPON MEDICAL SCHOOL, 2014, 81 (01) : 28 - 34
  • [33] A phase II study of carboplatin and paclitaxel in esophageal cancer
    El-Rayes, BF
    Shields, A
    Zalupski, M
    Heilbrun, LK
    Jain, V
    Terry, D
    Ferris, A
    Philip, PA
    ANNALS OF ONCOLOGY, 2004, 15 (06) : 960 - 965
  • [34] Sequential gemcitabine-carboplatin followed by paclitaxel-carboplatin in the first-line treatment of advanced ovarian cancer:: A phase II study
    Mäenpää, JU
    Grénman, SE
    Jalkanen, JT
    Kuoppala, TA
    Leminen, AO
    Puistola, US
    Vuolo-Merilä, PM
    Yliskoski, MH
    GYNECOLOGIC ONCOLOGY, 2006, 101 (01) : 114 - 119
  • [35] Randomized phase II study of decitabine in combination with carboplatin compared with carboplatin alone in patients with recurrent advanced ovarian cancer
    Glasspool, R. M.
    Gore, M.
    Rustin, G.
    McNeish, I.
    Wilson, R.
    Pledge, S.
    Paul, J.
    Mackean, M.
    Halford, S.
    Kaye, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [36] Definitive Radiochemotherapy of Advanced Head and Neck Cancer with Carboplatin and Paclitaxel A Phase II Study
    Semrau, Robert
    Temming, Susanne
    Preuss, Simon Florian
    Klussmann, Jens Peter
    Guntinas-Lichius, Orlando
    Mueller, Rolf-Peter
    STRAHLENTHERAPIE UND ONKOLOGIE, 2011, 187 (10) : 645 - 650
  • [37] Paclitaxel and carboplatin, alone or with irradiation, in advanced or recurrent endometrial cancer: A phase II study
    Hoskins, PJ
    Swenerton, KD
    Pike, JA
    Wong, F
    Lim, P
    Acquino-Parsons, C
    Lee, N
    JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (20) : 4048 - 4053
  • [38] A phase I study of intraperitoneal topotecan in combination with intravenous carboplatin and paclitaxel in advanced ovarian cancer
    Bos, AME
    De Vos, FYFL
    de Vries, EGE
    Beijnen, JH
    Rosing, H
    Mourits, MJE
    van der Zee, AGJ
    Gietema, JA
    Willemse, PHB
    EUROPEAN JOURNAL OF CANCER, 2005, 41 (04) : 539 - 548
  • [39] Weekly paclitaxel and carboplatin (PC-W) for patients with primary advanced ovarian cancer: results of a multicenter phase-II study of the NOGGO
    Jalid Sehouli
    Dirk Stengel
    Alexander Mustea
    Oumar Camara
    Elke Keil
    Dirk Elling
    Peter Ledwon
    Bernd Christiansen
    Peter Klare
    Gerhard Gebauer
    Marina Schwarz
    Werner Lichtenegger
    Cancer Chemotherapy and Pharmacology, 2008, 61 : 243 - 250
  • [40] A phase-II study evaluatin safety and efficacy with weekly paclitaxel and carboplatin as a primary treatment for patients with advanced epithelial ovarian cancer (EOC).
    Safra, T.
    Molho, R. Bernstein
    Grisaru, D.
    Spigel, S.
    Geva, R.
    Matcejevsky, D.
    Inbar, M.
    Menzcer, J.
    Levy, T.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 274S - 274S
12345